Peyronie's Disease: Characteristics & Treatments

Main Category: Urology / Nephrology
Also Included In: Erectile Dysfunction / Premature Ejaculation
Article Date: 08 Jul 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Peyronie's disease is characterized by a plaque, or hard lump, that develops on the upper or lower side of the penis in layers containing erectile tissue. It starts with an inflammation and can develop into a hardened scar. Symptoms may develop slowly or appear overnight and they consist of reduced flexibility, pain, curved and shortened penis during erection. The curvature of the penis generally leads to lowered self-esteem and makes sexual intercourse difficult, almost impossible.

Some of the factors involved in Peyronie's disease can be: the existence of an infection, genetic predisposition, vascular problems, consumption of specific medicines, diabetes, hypertension, etc. The plaque itself is benign, or noncancerous. However, if not treated, the disease may lead to serious erectile dysfunction.

At first, the line of treatment for Peyronie's disease was to "watch and wait" to see whether the penile curvature resolved itself or worsened. When the latter occurred, the patient was given vitamin E treatment, even though its positive outcome is not scientifically proved.

Researchers also have injected chemical agents into the plaques, a procedure that also lacks scientific studies that confirm its effectiveness.

A more effective way of curing Peyronie's disease is surgery, a last resort procedure which raises the patient's risk of experiencing complete loss of erectile function, rigidity and shortening of the penis.

Fortunately, surgery is not the only option to treat Peyronie's diseases. Andromedical, a Spanish medical company, markets the andropenis®, a medical device using the principle of traction to straighten the penis with no side effect, as long as it is used on a penis in flaccidity. The first outcome should appear within three weeks of treatment and after 6 to 7 months, the patient will notice full results: a correction of up to 70 per cent curvature. Thanks to its efficiency, the andropenis® is recognized by famous doctors worldwide, such as Wendy Hurn, Urology Specialist Practitioner, Bristol Royal Infirmary, UK.

Several scientific studies have confirmed the effectiveness of the andropenis® for patients with Peyronie's disease. Apart from rectifying penile curvatures, the andropenis® can also be used as a penile postoperative treatment in order to avoid scar retraction and especially to achieve a penis enlargement of 3 to 4 centimetres (1.2 to 1.6 inches) in length as well as a girth increase of 1,5 centimetre (0.6 inch) with a 97.5 percent rate of efficiency as demonstrated by independent scientific research around the globe.

www.andromedical.org